Taylor Devices (NASDAQ:TAYD) and Ekso Bionics (NASDAQ:EKSO) are both small-cap industrial products companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings.

Profitability

This table compares Taylor Devices and Ekso Bionics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Taylor Devices 3.52% 3.11% 2.66%
Ekso Bionics -303.58% -217.88% -103.68%

Volatility and Risk

Taylor Devices has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Comparatively, Ekso Bionics has a beta of 0.1, meaning that its stock price is 90% less volatile than the S&P 500.

Valuation and Earnings

This table compares Taylor Devices and Ekso Bionics’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Taylor Devices $24.36 million 1.71 $440,000.00 N/A N/A
Ekso Bionics $7.35 million 17.71 -$29.12 million ($0.89) -2.40

Taylor Devices has higher revenue and earnings than Ekso Bionics.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Taylor Devices and Ekso Bionics, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Taylor Devices 0 0 0 0 N/A
Ekso Bionics 0 0 0 0 N/A

Institutional and Insider Ownership

16.2% of Taylor Devices shares are held by institutional investors. Comparatively, 38.4% of Ekso Bionics shares are held by institutional investors. 4.8% of Taylor Devices shares are held by insiders. Comparatively, 35.5% of Ekso Bionics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Taylor Devices beats Ekso Bionics on 7 of the 10 factors compared between the two stocks.

Taylor Devices Company Profile

Taylor Devices, Inc. designs, develops, manufactures, and markets shock absorption, rate control, and energy storage devices for use in machinery, equipment, and structures in North America, Asia, and internationally. The company's products include seismic dampers that are designed to ameliorate the effects of earthquake tremors on structures; Fluidicshoks, which are compact shock absorbers primarily used in defense, aerospace, and commercial industries; and crane and industrial buffers, which are larger versions of the Fluidicshoks for industrial application on cranes, ships, container ships, railroad cars, truck docks, ladle and ingot cars, ore trolleys, and car stops. Its products also comprise self-adjusting shock absorbers that include versions of Fluidicshoks, and crane and industrial buffers, which automatically adjust to various impact conditions and are designed for high cycle application primarily in the heavy industry; liquid die springs that are used as component parts of machinery and equipment used in the manufacture of tools and dies; vibration dampers, which are primarily used by aerospace and defense industries to control the response of electronics and optical systems subjected to air, ship, or spacecraft vibration; machined springs used in the aerospace applications; and custom actuators for special military and aerospace applications. The company markets its products through a network of sales representatives and distributors. Taylor Devices, Inc. was founded in 1955 and is headquartered in North Tonawanda, New York.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness. The company's Ekso device is primarily used in a clinic or rehabilitation setting. It also performs research and development work on human exoskeletons and related technologies. The company has a license agreement with Lockheed Martin Corporation, Regents of the University of California, and Garrett Brown, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California. Ekso Bionics Holdings, Inc. operates as a subsidiary of Magee Rehabilitation Hospital.

Receive News & Ratings for Taylor Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taylor Devices and related companies with MarketBeat.com's FREE daily email newsletter.